Defense Logistics Agency: nerve agent antidote auto-injectors from Meridian Medical Technologies
Meridian Medical Technologies of St. Louis, Missouri, received a one-year option worth a maximum of $75,240,000 for antidote treatment nerve agent auto-injectors. The ordering period ends November 15, 2027.
Source: Department of War, Contracts for Nov. 16, 2026
DefMatch
Claim your profile
Do you sell to these buyers?
DefMatch is the Defense Capability Exchange from The Defense Post. Find your company profile, claim it, and get in front of the people placing these orders.